From the discovery of
penicillin to the hypothesized double-helix DNA model, medical science has made
significant advances in the past century that has extended the average life
span of the human being and saved countless lives. Cancerous tumors can be
caught by the click of a button in their early stages, premature babies can
live to be healthy, normal children, and sterile husbands can go through
procedures to allow their wives to have children. Now in the 21st
century, research is being done to create tests and procedures that will dig
deep into human DNA to reveal the probabilities individuals have to contracting
certain diseases and even personality traits. Paired with ever-advancing modern
technology, the genetics branch of medical science is making progress and will
soon offer a revolutionary kind of procedure—one that will not only predict the
predispositions of an individual’s body, but one that will also change the
entire field of genetics and change the way how humans are able to live.
On the 21st of May 2008, the Genetic
Information Nondiscrimination Act (GINA) was enacted under the Bush
Administration. Geneticists around the country came together to push for the
passing of this legislation to protect citizens from discrimination based on
what their genetic information indicates. The act, according to the National
Human Genome Research Institute, basically protects individuals “from discrimination
in both health insurance and employment.”
Now,
the question is, what can one’s genome, or the entire DNA in an organism
including its genes, reveal about the human body other than simply providing
original finger prints and indicating gender? According to Sam Rhine, genetics
professor at Indiana University and speaker of Genetic Update Conferences, “the
number and placement of polymorphism variants in the 3,000,000 DNA nucleotides”
can predict whether an individual has a high chance for prostate cancer or is
likely to have anger management issues.
The
name of this revolutionary project is the Genome Wide Association Studies
(GWAS). These GWAS tests utilize Comparative Genomic Hybridization (CGH)
technology in the form of a two different glass chips. One, the DNA chip,
probes for fragments and the presence of variants on an individual’s DNA. The
other chip, the ‘Gene’ chip, contains 1.8 million genetic markers that will
read an individual’s genes. These chips
have the ability to give percentage probabilities on how likely an individual
is likely to succumb to depression, contract breast cancer, or if they will be
optimistic individuals.
However,
critics of the GWAS project and GINA argue that though geneticists may only
have good intentions, the ethics surrounding these efforts are not to be
ignored. Questions are being raised about who should have access to genetic
testing results, how these tests should be evaluated for reliability and
accuracy, or how the public should be educated in making decisions regarding
these genetic tests. Many individuals also simply want to live life without the
thought of percentages and probabilities of contracting Alzheimer’s disease or
hypertension looming over their minds.
Upon the completion and perfection of the GWAS project,
researchers and doctors will soon be able to use the projects’ results to help
treat patients as well as help patients to take steps towards preventing any of
their body’s predispositions. These microchips hold the ability to change the
way patients are treated. While critics may question the usefulness and
validity of these tests, it is indisputable that more and more diseases may be
prevented even before early symptoms and parents may be able to find out the
personality of their unborn baby. Thanks to 21st century technology,
all these goals may be made possible within the next five years and will
forever change the field of genetics and the way humans will be medically
treated.
Works
Cited
Human
Genome Project Information. U.S. Department of Energy Genome
Programs. Web.
Mar.
2013
National
Human Genome Research Institute. National Institutes of
Health. Web. Mar. 2013
Rhine, Sam. “Genetics
Update Conference.” Walter Payton College Preparatory School.
Chicago,
IL. 28 February 2013.
No comments:
Post a Comment